Antonios Drakopoulos

Dr. Antonios Drakopoulos

Chemistry and Molecular Biology, University of Gothenburg, Gothenburg, Västra Götaland, Sweden
orcid
Medicinal chemist & chemical biologist | Computational & exp...

Biography

Antonios Drakopoulos is a medicinal chemist and chemical biologist with extensive experience in computational and experimental drug discovery. He combines expertise in organic synthesis, chemical biology, and computer-aided drug design to advance small-molecule therapeutics. Antonios has worked in industrial R&D at AstraZeneca and NovaMechanics Ltd., contributing to projects across the Early CVRM portfolio, including small molecules and PROTACs, integrating molecular modeling, docking, free energy calculations, and machine learning-driven approaches. His academic experience spans PhD research on opioid receptor oligomerization at the University of Würzburg, postdoctoral work on covalent probes in kinase chemical biology at the University of Gothenburg, and international research stays at University of Minho and University of Birmingham. He has been awarded prestigious fellowships and honors, including a Marie Skłodowska-Curie EUTOPIA-SIF fellowship, participation in the 71st Lindau Nobel Laureate Meeting, and first prize in the Merck Compound Challenge (2022) as part of Team UGOT. His research output includes publications in leading journals such as J. Med. Chem. - ACS and Angew. Chem. - Wiley, along with invited contributions to the EuroMedChem Talents Collection (ChemMedChem). Antonios has supervised MSc students, taught undergraduate chemistry courses, and collaborates across multidisciplinary teams, bridging computational and experimental disciplines in drug discovery.

Affiliations

University of Gothenburg

Gothenburg, Västra Götaland, Sweden

Chemistry and Molecular Biology

Honors and Awards

honor

1st prize (10.000 €) in Merck 4th Compound Challenge 2022 - Team UGOT

Merck KGaA Darmstadt Germany

The Merck Compound Challenge is a world-wide Retrosynthesis competition to identify the best synthetic route for a given small molecule competition. The participating teams get a structure of a challenging small molecule announced and develop a synthetically feasible route within 72 hours. The routes are evaluated and rated by experts on aspects like sustainability, required steps and creativity. The top 10 proposals are explored in a chemistry wet lab and the best one wins.

honor

71st Lindau Nobel Laureate Meeting – Chemistry 2022

Lindau Nobel Laureate Meetings Association

Qualification in a global multi-step selection process for one of the 600 young scientist positions participating in the 71st Lindau Nobel Laureate Meeting – Chemistry

honor

Invited publication in Early-Career Special Collection “EuroMedChemTalents”

EFMC & ChemMedChem – Wiley-VCH GmbH.

Contributing Authors featured in the "EuroMedChem Talents" Special Collection are nominated by the EFMC or the ChemMedChem editors and board members. These authors are considered figures that will shape the future of research at the interface of chemistry, biology, and medicine. DOI: doi.org/10.1002/cmdc.202200169

honor

(MSCA-COFUND) ΕUTOPIA Science and Innovation Individual Fellowship

Marie Skłodowska Curie Actions (MSCA) / EUTOPIA European University

Project title: "Development of traceless affinity tags for labelling Bruton’s Tyrosine Kinase" Hosting research group: Prof. Morten Grøtli, Department of Chemistry and Molecular Biology This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 945380.

honor

Marie Skłodowska Curie Actions – Research and Innovation Staff Exchange Fellowship (MSCA-RISE)

Marie Skłodowska Curie Actions (MSCA)

Staff exchange fellowship Horizon 2020 project: EthnoHERBS (grant agreement No 823973) Department of Biology, University of Minho, Braga, Portugal. Research groups: Prof. Rui Oliveira, Prof. Alberto Dias.

honor

EFMC-YMCS 2019 Poster Prize

EFMC-YMCS

6th EFMC Young Medicinal Chemist Symposium, Athens, Greece. Poster title: "Synthesis of new kappa opioid receptor-selective fluorescent probes and application for homodimerization studies under physiological conditions via Single Molecule Microscopy." - P022

Experience

Senior Scientist or Principal Investigator

AstraZeneca, Mölndal, Sweden

01 Aug 2023 - 01 Jul 2025

Post Doctoral Researcher

University of Gothenburg, Gothenburg, Sweden

01 Oct 2021 - 01 Aug 2023

Senior Scientist or Principal Investigator

NovaMechanics (Cyprus), Nicosia, Cyprus

01 Jan 2021 - 01 Oct 2021

Graduate Student or Post Graduate

Institute of Pharmacy and Food Chemistry, University of Würzburg, Würzburg, Germany

01 Dec 2014 - 01 Jun 2020

Graduate Student or Post Graduate

Department of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece

01 Oct 2012 - 01 Nov 2014

Undergraduate Student

Department of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece

01 Oct 2005 - 01 Dec 2011